Homozygous PMS2 Deletion Causes a Severe Colorectal Cancer and Multiple Adenoma Phenotype Without Extraintestinal Cancer-Reference-Cited by-同舟云学术

Homozygous PMS2 Deletion Causes a Severe Colorectal Cancer and Multiple Adenoma Phenotype Without Extraintestinal Cancer

Published:2007-02 Issue:2 Volume:132 Page:527-530
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Will Olivia,Carvajal-Carmona Luis G.,Gorman Patricia,Howarth Kimberley M.,Jones Angela M.,Polanco-Echeverry Guadalupe M.,Chinaleong Jo-Anne,Günther Thomas,Silver Andrew,Clark Susan K.,Tomlinson Ian

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference10 articles.

1. DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones;Fiegler;Genes Chromosomes Cancer,2003

2. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation;Gill;Clin Cancer Res,2005

3. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes;de Vos;Biochem Soc Trans,2005

4. PMS2 mutations in childhood cancer;De Vos;J Natl Cancer Inst,2006

5. An unusual case of Turcot’s syndrome associated with ileal adenocarcinoma, intestinal non-Hodgkin’s lymphoma, and duodenal adenocarcinoma;Murphy;Fam Cancer,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biallelic PMS2 Mutations in a Family with Uncommon Clinical and Molecular Features;Genes;2022-10-26

2. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome;The American Journal of Human Genetics;2022-05

3. Germline loss-of-function variants in the base-excision repair gene MBD4 cause a Mendelian recessive syndrome of adenomatous colorectal polyposis and acute myeloid leukaemia;2021-04-28

4. RNF216 mediates neuronal injury following experimental subarachnoid hemorrhage through the Arc/Arg3.1‐AMPAR pathway;The FASEB Journal;2020-09-12

5. Colorectal Cancer in People with Intellectual Disabilities;Oncology;2018